Moreover, the proteomic analysis highlighted the control of a cluster of proteins involved in DNA damage response, chromatin and kinase activities, ferroptosis, FoxO signaling, and p53 signaling of ovarian cancer cells, suggesting a potential novel drug for treating ovarian cancer. The gene discussed is TP53; the disease is ovarian carcinoma.